| KOMISJA NADZORU FINANSOWEGO | |||||||||||
| Raport bieżący nr | 4 | / | 2016 | ||||||||
| Data sporządzenia: | 2016-04-19 | ||||||||||
| Skrócona nazwa emitenta | |||||||||||
| MILESTONE MEDICAL | |||||||||||
| Temat | |||||||||||
| Change in shareholding structure of the Company | |||||||||||
| Podstawa prawna | |||||||||||
| Art. 70 pkt 1 Ustawy o ofercie - nabycie lub zbycie znacznego pakietu akcji | |||||||||||
| Treść raportu: | |||||||||||
| Pursuant to Article 70 section 1 of the Act on Public Offering and the Conditions Governing the Introduction of Financial Instruments to Organized Trading and on Public Companies, Board of Directors of Milestone Medical Inc. (the “Company") informs, that on April 18, 2016, the Company received from their shareholders the notifications about change in the number of their voting rights on the Company’s General Meeting of Shareholders. The Company attaches the content of the received notifications. Legal basis: Art. 70 sec. 1 of the Act on Public Offering and the Conditions Governing the Introduction of Financial Instruments to Organized Trading and on Public Companies | |||||||||||
| Załączniki | |||||||||||
| Plik | Opis | ||||||||||
| notification_Wang_Tao_18042016.pdf | |||||||||||
| notification_Zhang_Lidong_18042016.pdf | |||||||||||
| notification_Zhu_Yun_18042016.pdf | |||||||||||
| notification_Milestone_Scientific_18042016.pdf | |||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| MILESTONE MEDICAL INC | |||||||||||||
| (pełna nazwa emitenta) | |||||||||||||
| MILESTONE MEDICAL | |||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | ||||||||||||
| NJ 07039 | . | ||||||||||||
| (kod pocztowy) | (miejscowość) | ||||||||||||
| South Orange Avenue Livingston | 220 | ||||||||||||
| (ulica) | (numer) | ||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | ||||||||||||
| (telefon) | (fax) | ||||||||||||
| (e-mail) | (www) | ||||||||||||
| 27-5484393 | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2016-04-19 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
